NO20065323L - 6-substituerte pyridoindolonderivater, fremstilling og anvendelse derav - Google Patents

6-substituerte pyridoindolonderivater, fremstilling og anvendelse derav

Info

Publication number
NO20065323L
NO20065323L NO20065323A NO20065323A NO20065323L NO 20065323 L NO20065323 L NO 20065323L NO 20065323 A NO20065323 A NO 20065323A NO 20065323 A NO20065323 A NO 20065323A NO 20065323 L NO20065323 L NO 20065323L
Authority
NO
Norway
Prior art keywords
preparation
alkyl
substituted
pyridoindolone derivatives
derivatives
Prior art date
Application number
NO20065323A
Other languages
English (en)
Inventor
Pierre Casellas
Yvette Muneaux
Bernard Bourrie
Jean-Marie Derocq
Samir Jegham
Camille-George Wermuth
Paola Ciapetti
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of NO20065323L publication Critical patent/NO20065323L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)

Abstract

Oppfinnelsen angår forbindelser av formel (I), hvor R1 = H, C1-C4 alkyl, -(CH2)mOH, -(CH2)mCN eller -(CH2)mNR9R10, R2 = H, eller C1-C4 alkyl, R3 = fenyl substituert med R6, R7, eller R8, R4 = en gruppe av formel (a), en heterosyklisk gruppe utvalgt fra formlene (b), (c), eller (d) og R5 = H, eller C1-C4 alkyl. Oppfinnelsen angår videre en fremstillingsmetode for nevnte forbindelser og terapeutisk anvendelse derav.
NO20065323A 2004-04-21 2006-11-20 6-substituerte pyridoindolonderivater, fremstilling og anvendelse derav NO20065323L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0404251A FR2869316B1 (fr) 2004-04-21 2004-04-21 Derives de pyridoindolone substitues en -6, leur preparation et leur application en therapeutique.
PCT/FR2005/000971 WO2005108398A1 (fr) 2004-04-21 2005-04-20 Derives de pyridoindolone substitues en -6, leur preparation, leur application en therapeutique.

Publications (1)

Publication Number Publication Date
NO20065323L true NO20065323L (no) 2006-12-08

Family

ID=34945552

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065323A NO20065323L (no) 2004-04-21 2006-11-20 6-substituerte pyridoindolonderivater, fremstilling og anvendelse derav

Country Status (31)

Country Link
US (1) US7812165B2 (no)
EP (1) EP1742947B1 (no)
JP (1) JP4809830B2 (no)
KR (1) KR20070002094A (no)
CN (1) CN100537568C (no)
AR (1) AR048932A1 (no)
AT (1) ATE405565T1 (no)
AU (1) AU2005240816A1 (no)
BR (1) BRPI0510060A (no)
CA (1) CA2562561A1 (no)
CR (1) CR8677A (no)
DE (1) DE602005009166D1 (no)
DK (1) DK1742947T3 (no)
EC (1) ECSP066918A (no)
ES (1) ES2313371T3 (no)
FR (1) FR2869316B1 (no)
HK (1) HK1106223A1 (no)
IL (1) IL178444A0 (no)
MA (1) MA28546B1 (no)
MX (1) MXPA06012127A (no)
MY (1) MY137599A (no)
NO (1) NO20065323L (no)
PL (1) PL1742947T3 (no)
PT (1) PT1742947E (no)
RU (1) RU2364595C2 (no)
TN (1) TNSN06337A1 (no)
TW (1) TW200538114A (no)
UA (1) UA85709C2 (no)
UY (1) UY28864A1 (no)
WO (1) WO2005108398A1 (no)
ZA (1) ZA200608646B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2823975B1 (fr) 2001-04-27 2003-05-30 Sanofi Synthelabo Nouvelle utilisation de pyridoindolone
FR2846329B1 (fr) 2002-10-23 2004-12-03 Sanofi Synthelabo Derives de pyridoindolone substitues en -3 par un phenyle, leur preparation et leur application en therapeutique
US7456193B2 (en) 2002-10-23 2008-11-25 Sanofi-Aventis Pyridoindolone derivatives substituted in the 3-position by a heterocyclic group, their preparation and their application in therapeutics
FR2892416B1 (fr) * 2005-10-20 2008-06-27 Sanofi Aventis Sa Derives de 6-heteroarylpyridoindolone, leur preparation et leur application en therapeutique

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1268772A (en) 1968-03-15 1972-03-29 Glaxo Lab Ltd NOVEL alpha-CARBOLINE DERIVATIVES, THE PREPARATION THEREOF AND COMPOSITIONS CONTAINING THE SAME
US4263304A (en) * 1978-06-05 1981-04-21 Sumitomo Chemical Company, Limited 7 H-indolo[2,3-c]isoquinolines
SU833971A1 (ru) 1979-07-10 1981-05-30 Ленинградский Химико-Фармацевтическийинститут Способ получени 3-фенил-2-оксо- - КАРбОлиНОВ
FR2595701B1 (fr) * 1986-03-17 1988-07-01 Sanofi Sa Derives du pyrido-indole, leur application a titre de medicaments et les compositions les renfermant
JPH10501686A (ja) 1994-04-13 1998-02-17 ザ ロックフェラー ユニヴァーシティ 神経系の細胞へのｄｎａのａａｖ仲介送達
DE19502753A1 (de) * 1995-01-23 1996-07-25 Schering Ag Neue 9H-Pyrido[3,4-b]indol-Derivate
FR2765582B1 (fr) 1997-07-03 1999-08-06 Synthelabo Derives de 3-alkyl-1,9-dihydro-2h-pyrido[2,3-b]indol-2-one leur preparation et leur application en therapeutique
FR2765581B1 (fr) * 1997-07-03 1999-08-06 Synthelabo Derives de 3-aryl-1,9-dihydro-2h-pyrido[2,3-b]indol-2-one, leur preparation et leur application en therapeutique
CA2326319A1 (en) 1998-04-02 1999-10-14 Neurogen Corporation Aminoalkyl substituted 5,6,7,8-tetrahydro-9h pyrimidino[2,3-b]indole and 5,6,7,8-tetrahydro-9h-pyrimidino[4,5-b]indole derivatives: crf1 specific ligands
IT1313592B1 (it) 1999-08-03 2002-09-09 Novuspharma Spa Derivati di 1h-pirido 3,4-b indol-1-one.
US20020156016A1 (en) 2001-03-30 2002-10-24 Gerald Minuk Control of cell growth by altering cell membrane potentials
FR2823975B1 (fr) * 2001-04-27 2003-05-30 Sanofi Synthelabo Nouvelle utilisation de pyridoindolone
FR2846330B1 (fr) 2002-10-23 2004-12-03 Sanofi Synthelabo Derives de pyridoindolone substitues en -3 par groupe heterocyclique, leur preparation et leur application en therapeutique
US7456193B2 (en) * 2002-10-23 2008-11-25 Sanofi-Aventis Pyridoindolone derivatives substituted in the 3-position by a heterocyclic group, their preparation and their application in therapeutics
FR2846329B1 (fr) * 2002-10-23 2004-12-03 Sanofi Synthelabo Derives de pyridoindolone substitues en -3 par un phenyle, leur preparation et leur application en therapeutique
FR2892416B1 (fr) * 2005-10-20 2008-06-27 Sanofi Aventis Sa Derives de 6-heteroarylpyridoindolone, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
JP4809830B2 (ja) 2011-11-09
KR20070002094A (ko) 2007-01-04
MA28546B1 (fr) 2007-04-03
FR2869316A1 (fr) 2005-10-28
EP1742947A1 (fr) 2007-01-17
CA2562561A1 (fr) 2005-11-17
HK1106223A1 (en) 2008-03-07
ES2313371T3 (es) 2009-03-01
RU2006140998A (ru) 2008-05-27
AR048932A1 (es) 2006-06-14
CN1956986A (zh) 2007-05-02
MXPA06012127A (es) 2007-01-31
US20070129365A1 (en) 2007-06-07
BRPI0510060A (pt) 2007-10-16
FR2869316B1 (fr) 2006-06-02
MY137599A (en) 2009-02-27
IL178444A0 (en) 2007-02-11
JP2007533710A (ja) 2007-11-22
CR8677A (es) 2007-08-28
CN100537568C (zh) 2009-09-09
WO2005108398A1 (fr) 2005-11-17
RU2364595C2 (ru) 2009-08-20
DE602005009166D1 (de) 2008-10-02
ZA200608646B (en) 2008-02-27
ATE405565T1 (de) 2008-09-15
AU2005240816A1 (en) 2005-11-17
TW200538114A (en) 2005-12-01
US7812165B2 (en) 2010-10-12
TNSN06337A1 (en) 2008-02-22
UA85709C2 (ru) 2009-02-25
PT1742947E (pt) 2008-11-25
UY28864A1 (es) 2005-11-30
ECSP066918A (es) 2007-01-26
PL1742947T3 (pl) 2009-01-30
DK1742947T3 (da) 2009-01-05
EP1742947B1 (fr) 2008-08-20

Similar Documents

Publication Publication Date Title
CY1107008T1 (el) Παραγωγο βενζιμιδαζολης και χρηση ως ανταγωνιστου υποδοχεα aii
NO20063446L (no) Tiazolderivater
EA200800285A1 (ru) Новые производные 2,4-дианилинопиримидинов, их получение, лекарственные средства, фармацевтические композиции, содержащие указанные производные, и их применение, в частности, в качестве ингибиторов ikk
MX2009008465A (es) Nuevas 2-aminooxazolinas como ligandos de taar1.
NO20072371L (no) Kinuklidinderivater og deres anvendelse som muskarine M3-reseptorantagonister
NO20092770L (no) Nye aminopyrimidinderivater som PLK1-inhibitorer
SMT201300085B (it) Composti di pirrolo
NO20071642L (no) N-Benzensulfonylsubstituerte anilino-pyrimidinanaloger
RU2009102535A (ru) Производные карбамидов тропана, их получение и их применение в терапии
DE602005005167D1 (de) 1-isopropyl-2-oxo-1,2-dihydropyridin-3-carbonsäureamidderivate mit agonistischer wirkung am 5-ht4-rezeptor
NO20074763L (no) (1,5-difenyl-1H-pyrazol-3-yl)oksadiazolderivater, fremgangsmate ved fremstilling derav og anvendelse av samme i terapi
AR053405A1 (es) Derivados de urea sustituidas, composiciones farmaceuticas y metodos para el tratamiento de cardiopatias
EA201170096A1 (ru) Замещенные производные пиримидона
EA201071012A1 (ru) Производные азетидинов, способ их получения и применение их в терапии
CO5690599A2 (es) Derivados de 3-(4-aminofenil) tienopirimid-4-ona como antagonistas mch r1 para el tratamiento de obesidad, diabetes, depresion y ansiedad
NO20080738L (no) Fremgangsmater for neurobeskyttelse
AR057433A1 (es) Compuestos quimicos derivados de piridopirimidina, un metodo para su preparacion y composicion farmaceutica
MX2010001774A (es) Pirrolidin aril-eteres como antagonistas de receptores de nk3.
NO20072409L (no) Substituerte n-sulfonylaminobenzyl-2-fenoksy acetamid-forbindelser
AR068376A1 (es) Amidas heterociclicas utiles para inhibir la via hedgehog.
AR068115A1 (es) Derivado del acido pirazolcarboxilico metodo de produccion del mismo y fungicida
NO20062936L (no) Fremgangsmate for fremstilling av N-alkyl-2(hydroksy-4-benzoyl)-3-benzofuraner og dets mellomprodukter derav
MX2010009092A (es) Nuevos derivados de 3-aminoalquil-1,3-dihidro-2h-indol-2-ona, su preparacion y su aplicacion en terapeutica.
NO20063111L (no) Fremgangsmate for fremstilling av tiazolpyrimidiner
NO20065323L (no) 6-substituerte pyridoindolonderivater, fremstilling og anvendelse derav

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application